Acrivon Therapeutics, Inc.

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G) (amendment)

General form for quarterly reports under Section 13 or 15(d)

Results of Operations and Financial Condition

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Additional Information for Proxy Statement/ Votes

General form for quarterly reports under Section 13 or 15(d)

Results of Operations and Financial Condition

Annual Report Scanned (Paper)

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Annual report pursuant to Section 13 or 15(d)

Results of Operations and Financial Condition

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Termination of a Material Definitive Agreement

Regulation FD Disclosure

Regulation FD Disclosure

Results of Operations and Financial Condition

General form for quarterly reports under Section 13 or 15(d)

Results of Operations and Financial Condition

Regulation FD Disclosure

General form for quarterly reports under Section 13 or 15(d)

Results of Operations and Financial Condition

Submission of Matters to a Vote of Security Holders

General form for quarterly reports under Section 13 or 15(d)

Results of Operations and Financial Condition

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Annual Report Scanned (Paper)

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Regulation FD Disclosure

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Annual report pursuant to Section 13 or 15(d)

Regulation FD Disclosure

Results of Operations and Financial Condition

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

General form for quarterly reports under Section 13 or 15(d)

Results of Operations and Financial Condition

7.01,8.01,9.01

7.01,8.01,9.01

General form for quarterly reports under Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

Notice of Effectiveness

Annual Report Scanned (Paper)

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Correspondence with the SEC

Letter from the SEC

Registration statement under Securities Act of 1933

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Annual report pursuant to Section 13 or 15(d)

Notice of Effectiveness

Correspondence with the SEC

Letter from the SEC

Registration statement under Securities Act of 1933

General form for quarterly reports under Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Required Information in Proxy Statement

General form for quarterly reports under Section 13 or 15(d)

Annual Report Scanned (Paper)

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Annual report pursuant to Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Prospectus Supplement with Pricing Information

No description available

Free Writing Prospectus

No description available

Notice of Effectiveness

Amended Initial Registration Statement

Certification of approval for listing and registration on a national securities exchange

Correspondence with the SEC

Correspondence with the SEC

Registration of Securities on Exchange

Amended Initial Registration Statement

Correspondence with the SEC

Letter from the SEC

Draft registration statement (confidential submission) (amendment)

No description available

No description available

Letter from the SEC

Draft registration statement (confidential submission)

Levin Michaela

Levin Michaela

Blume-Jensen Peter; Masson Kristina

Blume-Jensen Peter

Devroe Eric

Peterson Katharine

Miller Mary

Blume-Jensen Peter; Masson Kristina

Gamelin Erick

Levy Adam D.

Miller Mary

Shacham Sharon

TOMSICEK MICHAEL JOHN

RA Capital Healthcare Fund LP; RA CAPITAL MANAGEMENT, L.P.; RA Capital Nexus Fund II, L.P.; Shah Rajeev M.; Kolchinsky Peter

DiRocco Derek

Magovcevic-Liebisch Ivana

Palani Santhosh

BAUM CHARLES M

Blume-Jensen Peter; Masson Kristina